Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Myelodysplastic Syndromes
•
General Internal Medicine
•
Rheumatology
•
Hematology
•
General Rheumatology
•
Relapsing polychondritis
•
Dermatology
•
VEXAS
In older male patients with a history of underlying autoimmune disease, what clinical manifestations would prompt you to evaluate for VEXAS Syndrome?
Related Questions
How would you approach management of an elderly patient with known mantle cell lymphoma and new diagnosis of cryoglobulinemic vasculitis with mild skin involvement, fatigue, arthralgias but no other major organ involvement?
How do you approach a patient with high titer ANA and a new diagnosis of ITP, but no other signs or symptoms suggestive of active rheumatologic disease?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
What is your approach to treatment of airway involvement, such as recurrent bronchial stenosis, in relapsing polychondritis?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
For patients with VEXAS syndrome and good response to azacitidine, what duration of therapy do you consider?
Can lupus anticoagulant be positive despite a normal aPTT?
Is there any benefit to checking serum viscosity in patients with autoimmune disease and headaches/migraines to see if aspirin or clopidogrel may be beneficial?
Have you utilized JAK inhibitors in patients on dialysis?
